Literature DB >> 21881513

The use of a cystic fibrosis patient registry to assess outcomes and improve cystic fibrosis care in Germany.

Martin Stern1.   

Abstract

PURPOSE OF REVIEW: Cystic fibrosis (CF) patient registries have become an important epidemiological tool for demography, networking, and quality management. This review describes recent developments in patient registries, outcome research, and pilot projects in quality improvement. RECENT
FINDINGS: National and international CF registry efforts have been producing consolidated data. Classical outcome indicators describing nutritional status and lung function are now being used in a more precise way, based on body mass index percentiles and longitudinal data. Projects involving single centers and quality groups, such as the German benchmarking project, have been showing that quality improvement is possible and that negative developments do not necessarily have to be accepted in CF.
SUMMARY: CF provides a model of the link between healthcare delivery and outcomes in patients. CF registry data can be used to improve quality in CF healthcare. Quality improvement is a continuous endeavor involving the reinforcement of standards and programs as well as individual attitudes and soft skills. One particularly powerful technique is benchmarking, that is, learning from the best.
© 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins

Entities:  

Mesh:

Year:  2011        PMID: 21881513     DOI: 10.1097/MCP.0b013e32834b6b72

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  3 in total

1.  Effectiveness and cost-effectiveness of guided Internet- and mobile-based CBT for adolescents and young adults with chronic somatic conditions and comorbid depression and anxiety symptoms (youthCOACHCD): study protocol for a multicentre randomized controlled trial.

Authors:  Frederike Lunkenheimer; Matthias Domhardt; Agnes Geirhos; Reinhold Kilian; Annabel S Mueller-Stierlin; Reinhard W Holl; Thomas Meissner; Kirsten Minden; Morten Moshagen; Ramona Ranz; Cedric Sachser; Doris Staab; Petra Warschburger; Harald Baumeister
Journal:  Trials       Date:  2020-03-12       Impact factor: 2.279

2.  Sustained Reduction in Time to Data Entry in the Cystic Fibrosis Foundation Registry.

Authors:  Laura Nay; Jame' Vajda; Sharon McNamara; Thida Ong
Journal:  Pediatr Qual Saf       Date:  2022-01-21

3.  A prospective investigation of developmental trajectories of psychosocial adjustment in adolescents facing a chronic condition - study protocol of an observational, multi-center study.

Authors:  Petra Warschburger; Ann-Christin Petersen; Roman E von Rezori; Friederike Buchallik; Harald Baumeister; Reinhard W Holl; Kirsten Minden; Annabel S Müller-Stierlin; Christina Reinauer; Doris Staab
Journal:  BMC Pediatr       Date:  2021-09-14       Impact factor: 2.125

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.